GRIN2B and drug-induced dyskinesia: It was partly explained by a de novo likely pathogenic variant in the GRIN2B gene (NM_000834.5:c.1246T>C; p.Phe416Leu) which causes a dominant neurodevelopmental disorder (OMIM #616139) with described abnormal movement disorders such as dystonia or dyskinesia [18].